health and wellness

Help Discover the Next Breakthrough Medical Treatment

Discovering treatments for better health

Published

3 years ago

August 28, 2022

Daily News Staff

(Family Features) Without clinical trials, the medicines millions of people rely on to treat or cure diseases would not have become available. Clinical trials examine the safety and effectiveness of new treatments in people, and this research plays a key role in developing ways to prevent, detect and treat diseases.

Why Diversity is Important in Clinical Trials

To ensure new treatments work well for all people, it is crucial for clinical trials to include volunteers from different backgrounds. Research shows people may have different reactions to treatments based on their race, ethnicity, gender, age and other factors, which makes it important for clinical trials to include a diverse range of participants. However, most clinical trials do not include participants that represent the diverse population of the United States.

Research in kidney disease provides a prime example of why such representation is important. Clinical trials have resulted in new treatments to slow damage to the kidneys and prevent kidney failure and death. However, despite having a greater chance of developing kidney failure, people of color remain underrepresented in kidney disease clinical trials.

About 33% of people with kidney failure are Black, but only about 1 in 10 clinical trial participants are Black, according to the American Kidney Fund (AKF). The disparity also exists for Hispanic people, who are nearly 1.5 times more likely to have kidney failure than non-Hispanics. However, only 1 in 10 clinical trial participants are Hispanic.

Many complex barriers contribute to a lack of diversity in clinical trials. Such barriers include mistrust among certain communities based on historical abuses, racial biases among health care providers, language and cultural differences and a lack of access to information about clinical trials and their safety measures.

“Clinical trials today have important safeguards to not only ensure the safety and fair treatment of participants but also ensure they meet ethical standards,” said LaVarne Burton, president and CEO of AKF. “These measures are critical toward achieving diversity and inclusion in clinical trials so approved treatments work well for those who so greatly need them.”

Learn More About Participating in Clinical Trials
People can join a clinical trial as a healthy volunteer or patient with the disease being studied. Clinical trials often benefit patients because they can receive access to world-class care and promising new treatments or medicines that are not yet available to the public.

Patients can always ask their doctors for recommendations about clinical trials they may qualify for, but this is not required. People can also find clinical trials on their own through reputable online resources.

Anyone interested in joining a clinical trial should gather as much information as possible about the study beforehand, such as what the study will entail, possible side effects and risks, and what type of time commitment is needed. Before taking part in a trial, talk with the treatment team about any concerns to ensure you have the confidence to make an informed decision about joining.

If you are interested in clinical trials related to kidney disease, you can find more resources about the clinical trial process and get matched with a clinical trial at kidneyfund.org/clinical-trials.

Photo courtesy of Getty Images

Help Discover the Next Breakthrough Medical Treatment

SOURCE:
American Kidney Fund

https://stmdailynews.com/category/lifestyle/health-and-wellness/health

Author

Daily News Staff

View all posts

Discover more from Daily News

Subscribe to get the latest posts sent to your email.

News

Healthcare Education Market – Skilling Up for Scalpels: Inside the Thriving Healthcare Education Industry

Published

8 hours ago

March 30, 2025

Daily News Staff

PUNE, MAHARASHTRA, INDIA /EINPresswire.com/ — Healthcare Education Market Perspective

The Global Healthcare Education Market size was worth USD 103.64 billion in 2022 and is estimated to grow to USD 202.75 billion by 2030, with a compound annual growth rate (CAGR) of approximately 8.75% over the forecast period. The report analyzes the healthcare education market’s drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the healthcare education market.

Healthcare Education Market Developments

• In 2023, HealthStream (US) purchased Electronic Education Documentation System, LLC (US). This acquisition will broaden Healthstream’s ecosystem by bringing a cutting-edge, cloud-based continuing education management system for healthcare organizations and delivering cutting-edge solutions in the form of Software-as-a-Service (SaaS).

• In 2022, To promote access for surgeons and benefit more patients across the US, GE Healthcare (US) and DePuy Synthes (US) worked together to make GE Healthcare’s OEC 3D Imaging System and DePuy Synthes’ extensive product line more widely available.

Get Access to Smart Book @ https://nforming.com/blog/healthcare/healthcare-education-market-analysis-report-industry-outlook-latest-development-and-forecast-to-2030/

Healthcare Education Market’s Top Driver

Increasing need for skilled healthcare workers to drive market growth

The market for healthcare education is expanding significantly due to the increasing need for skilled healthcare workers. The market for healthcare education is being significantly shaped by the growing demand for qualified healthcare workers. The demand for skilled physicians, nurses, allied health workers, and administrators who can deliver high-quality healthcare services is rising as the world’s population continues to expand and get older. The rising incidence of chronic illnesses and complicated medical disorders that need specialized care has increased this demand. Additionally, the need for healthcare professionals is growing outside conventional clinical responsibilities. The demand for non-clinical positions such as healthcare administrators, informatics experts, and others is also growing. As a result, healthcare education incorporates a variety of academic fields to produce a workforce that is well-rounded and able to meet the many demands of the healthcare sector.

Healthcare Education Market: Regional Landscape

Asia Pacific dominated the Healthcare Education market in 2022

There is a sizable and constantly expanding population in the Asia Pacific region, which generates a sizable demand for healthcare services. The demand for qualified and trained healthcare personnel grows proportionally as healthcare systems enlarge to meet this demand. Additionally, greater investments in healthcare infrastructure, including educational institutions, have been made as a result of the Asia Pacific region’s economic expansion. Governments and commercial organizations are becoming more aware of how crucial a strong healthcare education system is to the development of healthcare services.

Healthcare Education Market Top Players: Stryker (US), SAP (Germany), Adobe (US), Infor (US), Oracle (US), HealthStream (US), Symplr (US), Elsevier (Netherlands), Articulate (US), PeopleFluent (US), Fujifilm Corporation (Japan), GE Healthcare (US), Trivantis Corporation (US), Koninklijke Phillips (Netherlands), Siemens Healthineers (Germany), Coursera (US), and IBM (US).

Healthcare Education Market: Segmentation

The global healthcare education market has been segmented into provider, delivery mode, application, and end-user.

Based on universities, educational platforms, and medical simulation are segments of the global healthcare education market. The university segment to improve the business and department workers, the requirement for continuous learning in a field that is rapidly evolving, partnerships with healthcare organizations, and the emphasis on patient-centered care and interprofessional collaboration are all factors driving the growth of universities and academic institutions in the market for healthcare education solutions. The aforementioned elements help healthcare education programs grow and evolve to satisfy industry demands.

Based on delivery mode, the market is classified into classroom-based, and e-learning. In 2022, the e-learning processing category dominated the global market. Due to a variety of online learning platforms, students have access to educational resources like lectures, videos, quizzes, and other resources in a digital setting. Students can learn at their own pace and convenience in e-learning environments, which usually offer flexibility. Coursera, Blackboard, and Moodle are a few popular e-learning platforms. Because of the COVID-19 pandemic, e-learning platforms have proliferated as a medium of delivery, and this trend is anticipated to continue during the projected period. The overall revenue for Coursera in 2022 was US$523.8 million, a 26% increase over 2021, while the gross profit was US$249.5 million, a 33% increase over 2021.

Based on application, the market is classified into neurology, cardiology, and pediatrics. In 2022, the cardiology category dominated the global market. It is anticipated that factors including the increased prevalence of cardiovascular diseases (CVD), technological improvements, and online courses will raise demand for educational solutions. According to the WHO’s 2021 update, CVDs encompass illnesses like coronary heart disease, cerebrovascular disease, rheumatic heart disease, and others.

Based on end-users, the market is classified into students and physicians. In 2022, the student category dominated the global market. Student prospects have increased as a result of the growing accessibility and availability of healthcare education alternatives, notably online and remote learning options. Students can learn at their own pace, from any location, at any time, and with the help of digital tools and online platforms. This accessibility makes it easier for people from different backgrounds to enter the healthcare industry by allowing students to pursue healthcare education while juggling other responsibilities.

Trending Smart Book Reports:

Cardiac Biomarkers Market – https://nforming.com/blog/healthcare/cardiac-biomarkers-market-projected-to-grow-at-a-steady-cagr-of-12-60-during-forecast-period-2023-2030/

Fitness Trackers Market – https://nforming.com/blog/technology/global-fitness-trackers-market-insights-top-manufacturers-analysis-trend-and-demand-forecast-to-2030/

About Us

nForming Solutions also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to contact our sales team, who will ensure that you get a report per your needs.
Thanks for reading this article; you can also get individual chapter-wise sections or region-wise report versions like North America, Europe, or Asia.

Visit us on social media:
LinkedIn

Source: nForming Solutions

Author

Daily News Staff

View all posts

Discover more from Daily News

Subscribe to get the latest posts sent to your email.

News

Coca-Cola Recall Alert: Thousands of Cans Pulled From Shelves in Two States

Published

4 days ago

March 27, 2025

Hal Machina

selective focus photography of red coca-cola can lot on box — Photo by Craig Adderley on Pexels.com

In a significant recall notification, Coca-Cola has announced the withdrawal of over 10,000 cans of its popular beverage due to concerns over foreign object contamination. This announcement was initially made on March 6, and affected cans were sold in the states of Illinois and Wisconsin.

This week, the U.S. Food and Drug Administration (FDA) classified the risk level of this recall as Class 2. This designation indicates that consuming the affected Coca-Cola “may cause temporary or medically reversible adverse health consequences,” although the chances of serious health consequences are deemed to be remote.

Which Coca-Cola Products Were Recalled?

The recall impacts a total of 864 packs of 12 cans of Coca-Cola, amounting to 10,368 cans in total. The specific details of the recalled products are as follows:

Product Description: Coca-Cola Original Taste, 12 Fl Oz
Can UPC: 0 49000-00634 6
12-Can Pack UPC: 0 49000-02890 4
Date Code: SEP2925MDA
Time Stamp: 1100-1253

Which States Are Affected?

The recall specifically concerns Coca-Cola cans distributed in the following states:

Illinois
Wisconsin

Why Were the Coca-Cola Cans Recalled?

The FDA has reported that these Coca-Cola cans were recalled due to contamination with a foreign object, in this case, plastic. Such contaminants can inadvertently enter food and beverage products at various stages during the production process, posing a safety risk if ingested. It is important to note that the FDA report did not indicate any associated injuries related to this specific recall

If you have purchased Coca-Cola cans with the above UPC codes in Illinois or Wisconsin, it is recommended that you refrain from consuming the affected products. Instead, please return them to the store where you purchased them for a full refund or exchange. Staying informed about product recalls is crucial to consumer safety, and it is always advisable to check for the latest updates from the FDA and Coca-Cola regarding product safety issues. For any additional questions, feel free to reach out to Coca-Cola directly or visit the FDA’s website. Stay safe!

Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Lifestyle

Finding Clinical Trial Resources

Published

7 days ago

March 24, 2025

Daily News Staff

(Family Features) If you have Crohn’s disease or ulcerative colitis, a clinical trial may be an option for you. Clinical trials are necessary for finding new ways of preventing, detecting or treating these diseases and others. To learn more about inflammatory bowel disease clinical research, visit crohnscolitisfoundation.org/clinical-trials-community and consider resources from the Crohn’s & Colitis Foundation that can provide information on types of clinical trials, what to expect when participating in a clinical study, questions to ask your doctor, stories from clinical trial participants, how to find a clinical trial and more.